[TimAlerts] $LQMT Apple filed patent today. "Liquid Metal" material mentioned in the patent filing. Could get interesting. Nice timing by $LQMT on the manufacturing facility announcement. http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=5&f=G&l=50&co1=AND&d=PTXT&s1=%22Liquid+metal%22&OS=%22Liquid+metal%22&RS=%22Liquid+metal%22

[TimAlerts] $LQMT Robotics application too. http://www.techradar.com/news/nasa-has-found-a-way-to-make-robots-more-graceful-metallic-glass

[TimAlerts] $LQMT to purchase a new 41,000 square feet manufacturing facility. News out after the close. Stock was up 7% on the day. This was the one that has the patent relationship with Apple. Not saying that is what this is for. http://finance.yahoo.com/news/liquidmetal-purchase-manufacturing-facility-212000832.html

[TimAlerts] Checkout the candle at around 3:55PM today for MCIG. Drops nearly 10% then jumps right back up. Then the news comes out 6 minutes later at 4:01PM that MCIG was going to reduce number of shares outstanding by 5 million shares. Ya think MM's wanted those shares that were stopped out for the start of trading tomorrow?? Just a thought.

[TimAlerts] re: $MJNA they have a 15,000,000 share investment in AXIM. Position was purchased on or around July 1, 2015. Back then AXIM traded at ~$1 per share. Since then AXIM has run up to $13.20 a share. Nice ROI for $MJNA but has not been reflected in the share price. Run a chart Compare that overlays $MJNA & AXIM.

[TimAlerts] $8 looks like it will be a key level for IDXG. That is where the battle will be IMHO.

[TimAlerts] $NVAX going back to Ph2 as they are changing the protocol and the endpoints so have to study safety and efficacy for the various groups.

[TimAlerts] $NVAX announcement after the bell: http://finance.yahoo.com/news/novavax-initiates-phase-2-safety-210601939.html

[TimAlerts] $NVAX kicking off a redo of it's failed Phase 3 trial for RSV. Running this trial in the Southern hemisphere. Their Ph. 3 failed (they think) due to an abnormally low attack rate in North America. Stock is bad sushi but worth keeping an eye on how it reacts. Zika vaccine announcement could follow but when nobody knows.

[TimAlerts] $APRI In @ 2.19 out at 2.91. Didn't want to sell but had to.